February 15, 2022

The Q4 Impact report features a summary of the forthcoming thematic on Liquid Biopsy – a promising alternative to traditional tissue-based biopsies. The team’s stock case studies take a look at diagnostics business, Qiagen and mechanical and plant engineering firm Duerr. Read our latest thematic report below.

Download report here

Regnan Global Equity Impact Solutions Fund

This fund is distributed in Australia via Pendal and in the UK, Europe and other countries via J O Hambro Capital Management.

Select your location: